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Abstract
Introduction: Syringomatous adenoma of the nipple is a very rare benign tumor. To the best of our knowledge,
there are no reports of a syringomatous adenoma of the nipple metastasizing, although these tumors are known to
infiltrate locally and to recur if not totally resected.
Case presentation: Our patient was a 41-year-old Japanese woman who complained of stiffness of her right
nipple with abnormal discharge. Local resection of the tumor was performed. The pathological diagnosis was
syringomatous adenoma of the nipple, and the resection margin was found to be positive. Accordingly, additional
resection was recommended, but our patient did not allow another operation. After 1.5 years of careful follow-up,
no local recurrence or distant metastasis has been observed.
Conclusion: The optimal initial management of syringomatous adenoma of the nipple demands complete
resection with histologically negative margins. However, from a cosmetic viewpoint, nipple-sparing resection could
represent an alternative option for the treatment of syringomatous adenoma of the nipple.
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Introduction
Syringomatous adenoma of the nipple (SAN) is a very
rare benign tumor that was first reported by Rosen in
1983 [1]. SAN shows locally infiltrating growth but does
not metastasize [2]. Nonetheless, in some cases, this
tumor may be misdiagnosed as a malignancy owing to
its infiltrating growth pattern [3].
We present a rare case involving a 41-year-old
woman with SAN, who underwent tumor resection
with a histologically positive surgical margin, while
sparing the nipple.
Case presentation
A 41-year-old Japanese woman presented with firmness
of her right nipple and abnormal nipple discharge
(Fig. 1). The secretion was milky. She did not experience
any pain, itching, or ulceration on the skin, and no
lymph node swelling was detected at any site. No
abnormality was seen in her left breast, and all standard
laboratory test results were within the normal ranges.
No mass was observed upon mammography (MMG),
although the subareolar region was more dense on the
right side than the left. Moreover, foci of microcalcifica-
tion were observed. Similarly, ultrasonography did not
reveal an obvious mass. Magnetic resonance imaging
(MRI) showed a mass with an irregular outline in the
subareolar region of her right nipple. T1-weighted MRI
did not show any obvious mass in her subareolar region,
while a low signal density mass was observed on the T2-
weighted images (Fig. 2). A cytodiagnosis of the nipple
discharge did not indicate malignancy; however, the
above-mentioned findings could not fully substantiate its
benignancy. Hence, our patient consented to an inci-
sional biopsy of her nipple lesion. A vertical incision was
made to the right nipple skin along the Langer’s line,
and a white, stiff mass with ambiguous borders was
found in the subareolar area. As much of the tumor was
removed as possible, while sparing her nipple.
The resected tumor was whitish, round, solid, and firm
in consistency, and measured 7 mm in maximum diam-
eter. With regards to the histopathology, the tumor was
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composed focally of ducts and tubules lined by a double
layer of epithelial cells; the outer layer comprised small,
cuboidal cells with scanty cytoplasm, while the inner
layer consisted of rather flat cells with eosinophilic cyto-
plasm and centrally located small nuclei (Fig. 3). Many
of the proliferating ducts assumed a teardrop or comma-
shaped configuration. In addition, squamoid solid nests
were found scattered among them, and the tumor cells
infiltrated the stroma between the smooth muscle bun-
dles. Immunohistochemical staining for Ki-67 indicated
less than 5 % positivity. Although we were able to differ-
entiate nipple duct adenoma, tubular carcinoma, and
syringoma, the final pathological diagnosis was infiltrat-
ing syringomatous adenoma of the nipple. The clinical
and histological features allowed us to exclude other le-
sions. The resection margin was found to be positive.
Because the tumor was so closely located to the epi-
dermis of her nipple, additional resection of ample
breast parenchyma and her right nipple was originally
planned; however, our patient did not agree to immedi-
ate surgery. Although we explained the characteristics of
the tumor and proposed additional resection with nipple
preservation, our patient requested that surgery only be
performed in case of a relapse.
Accordingly, she was kept under close surveillance. No
local recurrence or distant metastasis was found during
a 1.5-year follow-up period. We will continue careful
monitoring for some years.
Discussion
SAN is an extremely rare benign tumor. To the best of
our knowledge, only 38 cases of SAN have been reported
in the English literature [2, 4–6], including 36 female
and 2 male cases. The age of these patients ranged from
11 to 87 years, with a mean age at presentation of 46.1
Fig. 1 Appearance of the right nipple. The right nipple felt firm, but
no mass was palpated. A milky secretion was noted. Our patient did
not complain of pain, itching, or ulceration
Fig. 2 Magnetic resonance imaging. T1-weighted magnetic resonance imaging (MRI) did not show an obvious mass in the subareolar region of
the right nipple (a). Conversely, T2-weighted MRI suggested a mass with low signal density (c white arrow). No mass was observed in the left side
upon T1-weighted (b) or T2-weighted MRI (d)
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years. The resected tumors measured 5–40 mm in size,
with a mean of 17.7 mm. Only two of these cases pre-
sented bilaterally [2, 6].
SANs commonly manifest as solitary firm masses in
the subareolar or nipple region of the unilateral breast,
and may also occur within the breast parenchyma. They
may be either clinically asymptomatic, tender and pain-
ful on palpation, and/or present with itching and ulcer-
ation [7]. Nipple inversion or discharge is noted on
occasion [8].
Upon MMG, SAN generally appears as a high-density
mass in the subareolar region with an irregular outline,
spicule formation, and microcalcification foci, while
ultrasonography shows an ill-defined mass with hetero-
geneous internal echoes [9]. MRI can depict the mass
more obviously than MMG. However, the imaging find-
ings of SANs resemble those of malignant tumors, and,
therefore, SAN may be indistinguishable from carcinoma
on imaging examinations such as MMG, ultrasonog-
raphy, and MRI [9].
Pathologically, the tumor grossly appears ill-defined,
with firm-to-resilient consistency and a gray or white
cut surface [1, 3]. Histologically, the lesion is composed
of tubules, ductules, and strands of small, uniform, gen-
erally basophilic cells infiltrating the dermis of the sur-
rounding skin and the stroma of the nipple [3].
Proliferating ducts, which are lined by a single or mul-
tiple layers of metaplastic squamous cells, may be
present. These cell nests have a teardrop or comma-
shaped appearance [10], and the tumor cells can infil-
trate the stroma between the smooth muscle bundles,
and even in the perineural region [9].
Nipple duct adenoma and well-differentiated tubular
carcinoma are often confused with SAN. These en-
tities, however, exhibit some distinctive characteristics.
Nipple duct adenoma often ulcerates the skin, is usu-
ally better circumscribed, and does not invade the
perineural region or smooth muscle bundles. Tubular
carcinoma tends to occur deeper in the breast and is
commonly located in the upper outer quadrant or
away from the nipple. If tubular carcinoma extends to
the nipple, it may cause nipple retraction and Paget’s
disease [11]. Syringoma also exhibits clinical features
that distinguish it from SAN, including presentation
as a solitary lesion in the nipple [1].
Some researchers have reported the usefulness of
immunohistochemical staining for p63 or S-100 pro-
tein [3, 6, 7]. However, in the present study we
performed staining for Ki-67, a prognostic and pre-
dictive marker for breast cancer [12]. Cells express
Ki-67 during the G1, S, G2, and M phases of the cell
cycle, but not during the resting phase G0 [12]. Ac-
cordingly, high Ki-67 levels indicate that a tumor
harbors a highly proliferative potential. In other
words, Ki-67 staining helps to distinguish between be-
nign and malignant tumors and to predict prognosis.
SAN has a tendency to show local recurrence when
resected incompletely [6]. Accordingly, the optimal ini-
tial management demands complete resection with his-
tologically negative margins [13]. If the margins appear
involved, re-excision is recommended [3]. However,
SAN often occurs in the dermis and subcutis regions of
the nipple or areola [9]; in such cases, proper manage-
ment necessitates total resection of the nipple–areolar
complex. Some patients, especially young women, hope
to retain the nipple. SAN is not a malignant tumor [1],
and there have been no reports of SAN with distant me-
tastasis [2]. If a patient requests preservation of the nip-
ple, even with sufficient informed consent, tumor
resection with nipple preservation should be considered.
Nipple-sparing resection can yield excellent cosmetic re-
sults. If the tumor is so close to the nipple that nipple
preservation is impossible, an appropriate treatment
regimen should be selected for the patient. In such
cases, however, careful postoperative monitoring is
mandatory. Jones et al. reported times to recurrence ran-
ging from 1.5 months to 4 years [11]. Accordingly, the
follow-up duration should exceed 5 years if complete re-
section is not performed.
Conclusion
We report the case of a 41-year-old woman with SAN.
Considering her background and preferences, we
resected the tumor while sparing her nipple. Considering
the characteristics of the tumor, we cannot recommend
nipple-sparing resection with positive margins. Although
Fig. 3 Micrograph of the tumor. Many of the proliferating ducts
assuming a teardrop or comma-shaped configuration (arrow heads)
were lined by double-layer or multiple-layer epithelial cells on
microphotography. Squamoid solid nests are also seen. The tumor
cells infiltrated the stroma between the smooth muscle bundles
(hematoxylin and eosin; original magnification ×400)
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SAN may recur if not completely resected, SAN is a
benign tumor and does not metastasize. With that
in mind, from a cosmetic viewpoint, nipple-sparing
resection can represent an alternative treatment option
for SAN. However, the treatment regimen should be
tailored to each patient. After nipple-sparing resection,
careful and regular monitoring is necessary.
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